help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0181
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
19/5/1200    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chuang, K.-H.
Right arrow Articles by Chang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chuang, K.-H.
Right arrow Articles by Chang, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*TRANS-RETINOIC ACID
Molecular Endocrinology 19 (5): 1200-1212
Copyright © 2005 by The Endocrine Society

9-cis-Retinoic Acid Inhibits Androgen Receptor Activity through Activation of Retinoid X Receptor

Kuang-Hsiang Chuang1, Yi-Fen Lee1, Wen-Jye Lin, Chin-Yi Chu, Saleh Altuwaijri, Yu-Jui Yvonne Wan and Chawnshang Chang

George Whipple Laboratory for Cancer Research, Department of Pathology (K.-H.C., Y.-F.L., W.-J.L., C.-Y.C., S.A., C.C.), University of Rochester Medical Center, Rochester, New York 14642; and Department of Pharmacology, Toxicology and Therapeutics (Y.-J.Y.W.), The University of Kansas Medical Center, Kansas City, Kansas 66160-7417

Address all correspondence and requests for reprints to: Chang Chawnshang, George Whipple Laboratory for Cancer Research, Department of Pathology, University of Rochester Medical Center, Rochester, New York 14642. E-mail: chang{at}urmc.rochester.edu; web site: www.urmc.rochester.edu/changARlab.

Although the retinoic X receptor (RXR) forms heterodimers with many members of the estrogen receptor subfamily, the interaction between RXR and the members of the glucocorticoid receptor subfamily remains unclear. Here we show that the RXR can form a heterodimer with the androgen receptor (AR) under in vitro and in vivo conditions. Functional analyses further demonstrated that the AR, in the presence or absence of androgen, can function as a repressor to suppress RXR target genes, thereby preventing the RXR binding to the RXR DNA response element. In contrast, RXR can function as a repressor to suppress AR target genes in the presence of 9-cis-retinoic acid, but unliganded RXR can function as a weak coactivator to moderately enhance AR transactivation. Together, these results not only reveal a unique interaction between members of the two nuclear receptor subfamilies, but also represent the first evidence showing a nuclear receptor (RXR) may function as either a repressor or a coactivator based on the ligand binding status.

NURSA Molecule Pages Link:

Nuclear Receptors:   RXRα  |  RXRβ  |  AR
Ligands:   Dihydrotestosterone  |  9-cis-Retinoic acid  |  R1881



This article has been cited by other articles:


Home page
Endocr. Rev.Home page
H. V. Heemers and D. J. Tindall
Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex
Endocr. Rev., December 1, 2007; 28(7): 778 - 808.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
E. C. Bolton, A. Y. So, C. Chaivorapol, C. M. Haqq, H. Li, and K. R. Yamamoto
Cell- and gene-specific regulation of primary target genes by the androgen receptor
Genes & Dev., August 15, 2007; 21(16): 2005 - 2017.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. E. Trasino, E. H. Harrison, and T. T. Y. Wang
Androgen Regulation of Aldehyde Dehydrogenase 1A3 (ALDH1A3) in the Androgen-Responsive Human Prostate Cancer Cell Line LNCaP
Experimental Biology and Medicine, June 1, 2007; 232(6): 762 - 771.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society